May 1 (Reuters) - Medical equipment maker Mettler-Toledo

International ( MTD ) lowered its annual profit forecast below

Wall Street estimates on Thursday, anticipating market

uncertainty and impact from tariffs.

The company estimates global tariff costs of about $115

million on an annualized basis and is implementing mitigating

actions this year that will fully offset these costs next year.

"The ongoing global trade disputes have significantly

increased uncertainty in global customer demand," said CEO

Patrick Kaltenbach.

The company now expects 2025 profit in the range of $41.25

to $42.00 per share, down from its previous range of $42.35 to

$43.00 per share. Analysts on an average expect $42.54 per

share, according to data compiled by LSEG.

Medical equipment makers like Revvity ( RVTY ) and Thermo

Fisher Scientific ( TMO ) have been warning about the impact of

tariffs imposed by the Trump administration.

The Columbus, Ohio-based firm reported first-quarter revenue

of $883.7 million, beating estimates of $876.57 million,

according to data compiled by LSEG.

On an adjusted basis, Mettler-Toledo ( MTD ) earned a profit of

$8.19 per share for the quarter ending March 31, surpassing

analysts' estimate of $7.89 per share.